Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
2 studies found for:    9918480 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Alternative Dosing and Regimen of Replagal to Treat Fabry Disease
Condition: Fabry Disease
Intervention: Drug: Replagal
2 Completed Replagal Enzyme Replacement Therapy for Adults With Fabry Disease
Condition: Fabry Disease
Interventions: Drug: Replagal (Agalsidase Alfa);   Drug: Replagal

Indicates status has not been verified in more than two years